• How a narrow-spectrum antibiotic takes aim at C. Diff

    1 month ago - By ScienceDaily

    New study reveals at a molecular level how fidaxomicin selectively targets C. Diff bacteria while sparing the innocent bacterial bystanders of the gut microbiome.
    Read more ...